Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

BioLife Solutions' CFO Sells 30,000 Shares

TheMotleyFool

0 0

BioLife Solutions' CFO Sells 30,000 Shares: https://cdn.content.foolcdn.com/images/1umn9qeh/production/5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png?w=1401&h=1251

This bioproduction tools provider for cell and gene therapy reported a notable insider sale amid a modestly downtrending share price.

Troy Wichterman, Chief Financial Officer of BioLife Solutions (NASDAQ:BLFS), directly sold 30,000 shares on Dec. 4, for a transaction value of approximately $771,600, according to the SEC Form 4 filing.

Transaction value based on SEC Form 4 weighted average sale price ($25.72); post-Transaction value based on Dec. 4 market close of $25.83 (price not specified in filing).

Source Fool.com